| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | 16.3A5 ELISA Kit; 1F5 ELISA Kit; 1F5 antigen ELISA Kit; 20 kDa homologous restriction factor ELISA Kit; CD 59 ELISA Kit; CD_antigen=CD59 ELISA Kit; CD59 ELISA Kit; CD59 antigen ELISA Kit; CD59 antigen complement regulatory protein ELISA Kit; CD59 antigen p18 20 ELISA Kit; CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5; EJ16; EJ30; EL32 and G344) ELISA Kit; CD59 glycoprotein ELISA Kit; CD59 molecule ELISA Kit; CD59 molecule complement regulatory protein ELISA Kit; CD59_HUMAN ELISA Kit; Cd59a ELISA Kit; Complement regulatory protein ELISA Kit; EJ16 ELISA Kit; EJ30 ELISA Kit; EL32 ELISA Kit; FLJ38134 ELISA Kit; FLJ92039 ELISA Kit; G344 ELISA Kit; HRF 20 ELISA Kit; HRF-20 ELISA Kit; HRF20 ELISA Kit; Human leukocyte antigen MIC11 ELISA Kit; Ly 6 like protein ELISA Kit; Lymphocytic antigen CD59/MEM43 ELISA Kit; MAC inhibitory protein ELISA Kit; MAC IP ELISA Kit; MAC-inhibitory protein ELISA Kit; MAC-IP ELISA Kit; MACIF ELISA Kit; MACIP ELISA Kit; MEM43 ELISA Kit; MEM43 antigen ELISA Kit; Membrane attack complex (MAC) inhibition factor ELISA Kit; Membrane attack complex inhibition factor ELISA Kit; Membrane inhibitor of reactive lysis ELISA Kit; MGC2354 ELISA Kit; MIC11 ELISA Kit; MIN1 ELISA Kit; MIN2 ELISA Kit; MIN3 ELISA Kit; MIRL ELISA Kit; MSK21 ELISA Kit; p18 20 ELISA Kit; Protectin ELISA Kit; Surface antigen recognized by monoclonal ELISA Kit 16.3A5 ELISA Kit; T cell activating protein ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates. |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
CD59 glycoprotein(CD59) is a biological molecule commonly studied in immunology research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P13987
Biological context
Researchers often monitor CD59 glycoprotein(CD59) in serum, plasma, and tissue homogenates. to better understand themes such as innate and adaptive immune responses, cytokine signaling networks, and host–pathogen interactions. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in CD59 glycoprotein(CD59) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, cytokines, chemokines, acute-phase proteins, and immune-cell activation markers) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, CD59 glycoprotein(CD59) may also appear under names such as 16.3A5 and 1F5. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that CD59 glycoprotein(CD59) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Can lipid mediators and free fatty acids guide acute coronary syndrome diagnosis and treatment?
G Uzun,Laboratory medicine,2024